Adrianne Ortega Previews 2026 Healthcare M&A Regulatory Strategy in Trending Video | News & Events

Attorneys:

In this Trending video, Ropes & Gray partner Adrianne Ortega discusses how proactive, strategic planning is critical for organizations navigating the increasingly complex regulatory landscape for 2026 healthcare transactions.

Large-scale healthcare M&A and cross-jurisdictional transactions are subject to increasing scrutiny; states are increasing oversight over healthcare transactions
Approach to regulatory strategy can impact structure, timing, and execution of transactions; a proactive and strategic approach enhances transaction execution
We help our clients navigate the evolving regulatory landscape and translate complex regulatory requirements into an integrated strategy

Please watch our 2026 Market Outlook video as well as other Trending videos on specific industry trends, including:

Please contact our health care team at [email protected] for a complimentary briefing on our 2026 healthcare market outlook and/or specific trends.

Transcript

Adrianne Ortega: I’m Adrianne Ortega, a partner in the health care practice. I advise healthcare organizations, academic medical centers, and investors on strategic transactions.

As healthcare deal activity rebounds, deal execution will increasingly turn on regulation. Across the country, states are expanding oversight of healthcare transactions and parties to large-scale or multi-state healthcare transactions now face a patchwork of inconsistent regulatory requirements. Transactions that might have closed easily just a few years ago, can encounter extensive regulatory review processes and significant delays.

In this environment, a party’s approach to the regulatory implications of a transaction can have a critical impact on structure, timing, and execution.

Executing a complex healthcare transaction requires proactive planning and analysis. This can involve initiating preliminary regulatory assessments, aligning leadership and stakeholders around a coherent regulatory approach, and integrating regulatory workstreams into deal timelines.

Experienced counsel accelerates this work by translating disparate state and federal requirements into an integrated strategy, sequencing filings and approvals, and engaging regulators constructively to keep transactions on track. In our experience leading complex healthcare transactions across the country, the most successful transactions embed a proactive and strategic approach to the regulatory process into overall deal strategy.